NEW YORK, June 27 (Reuters) - Staar Surgical Co. said on Wednesday it received a warning letter from U.S. health regulators informing the company that its response to concerns raised by an FDA inspection earlier this year was inadequate.
NEW YORK, June 27 (Reuters) - Staar Surgical Co. said on Wednesday it received a warning letter from U.S. health regulators informing the company that its response to concerns raised by an FDA inspection earlier this year was inadequate.
